FDA issues statement on new strategies to modernize clinical trials to advance precision medicine, patient protections and more efficient product development
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on new strategies to modernize clinical trials to advance precision medicine, patient protections and more efficient product development